Kura Oncology (NASDAQ: KURA) exec plans to sell 31,487 shares

Rhea-AI Filing Summary

Kura Oncology, Inc. (KURA) is named as the issuer in a planned resale of its common stock under Rule 144. Officer Teresa Bair filed notice to sell 31,487 shares of Kura common stock through Morgan Stanley Smith Barney LLC. The proposed sale is referenced with a date of 08/19/2026 on the NASDAQ market. The shares were acquired upon vesting of restricted stock units during the period from 01/26/2024 through 01/26/2026.

Key Figures

Shares to be sold: 31,487 shares Aggregate market value: $388,234.71 Proposed sale date reference: 08/19/2026 +3 more

6 metrics

Shares to be sold 31,487 shares Common stock covered by the Rule 144 notice for potential sale

Aggregate market value $388,234.71 Value associated with the 31,487 common shares in the Rule 144 filing

Proposed sale date reference 08/19/2026 Date listed alongside the common stock in the securities information section

Vesting period start 01/26/2024 Beginning of period in which restricted stock units vested

Vesting period end 01/26/2026 End of period in which restricted stock units vested

Date of notice 05/20/2026 Date on which the Form 144 notice was signed and filed

Key Terms

Rule 144, restricted stock units, Form 144

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock units financial

"The securities to be sold were acquired upon the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

What does the Form 144 filing mean for KURA stock?

The filing reports a planned resale of 31,487 Kura Oncology (KURA) shares under Rule 144 by officer Teresa Bair. It is a disclosure of potential share sales, not an issuance of new shares by Kura Oncology.

How many KURA shares are planned to be sold under this Form 144?

The notice covers up to 31,487 shares of Kura Oncology common stock. These shares were acquired from vested restricted stock units and are proposed to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ market.

Who is selling Kura Oncology (KURA) shares in this Form 144?

Officer Teresa Bair filed the Form 144 to sell shares of Kura Oncology. The shares are to be sold for her account through Morgan Stanley Smith Barney LLC, following acquisition via vested restricted stock units.

What is the approximate value of KURA shares covered by this Form 144?

The filing shows an aggregate value of about $388,234.71 tied to the 31,487 Kura Oncology shares. This figure reflects the market value used for the Rule 144 notice and not an executed sale price.

When were the KURA shares in this Form 144 acquired?

The shares were acquired upon vesting of restricted stock units during the period from 01/26/2024 through 01/26/2026. The Form 144 notes this vesting period in the remarks section as the source of the shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 04:24 PM Accepted by SEC EDGAR 08/19/2026 - 04:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001813058
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	KURA ONCOLOGY INC
SEC File Number	001-37620
Address of Issuer	4930 Directors Place, Suite 500 San Diego CALIFORNIA 92121
Phone	8585008800
Name of Person for Whose Account the Securities are To Be Sold	TERESA BAIR
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	31487	388234.71	88960619	08/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/26/2024	Restricted Stock Units	Issuer			31487	01/26/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 01/26/2024 through 01/26/2026.
Date of Notice	08/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Teresa Bair
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)